Firm
Maria Peyman, head of IP at Birketts, explains why the firm is adopting a ‘seamless approach’ for clients by integrating two of its practice areas
Lawyers at A&O Shearman analyse developments regarding UPC’s long-arm jurisdiction, including its scope and jurisdictional limits
Executive chair Matt Dixon, who reveals a new associate hire, says the firm wants to offer a realistic pathway to partnership while avoiding the ‘corporate machine’ route
Mayer Brown’s role in cardiovascular technology dispute reflects how firms are pursuing precedent-setting cases to try and guide AI and patent law
Sponsored
Sponsored
-
Sponsored by Remfry & SagarBisman Kaur of Remfry & Sagar says recent reports indicate the development of India’s intellectual property culture is continuing apace through progress in areas such as R&D, enforcement, and patent and trademark filings -
Sponsored by Tilleke & GibbinsWith agriculture a vitally important sector of Cambodia’s economy, Sokmean Chea and Vongkhim Lay of Tilleke & Gibbins provide a guide to the registration of new plant varieties in light of significant developments
-
Sponsored by Tilleke & GibbinsLinh Duy Mai and Giang Hoang Bach of T&G Law Firm LLC (TGVN), the local associate firm of Tilleke & Gibbins, explain why Decree 147 is to be welcomed, although a key issue is unresolved
-
Sponsored by Gün + PartnersUğur Aktekin and Begüm Soydan Sayılkan of Gün + Partners highlight several decisions concerning the Turkish Patent and Trademark Office’s well-known trademark registry and say clarification of its standing is eagerly awaited
-
Sponsored by MaiwaldChristian Meyer and Gisela Grabow of Maiwald consider proposals under the European Commission’s Action Plan for Intellectual Property that aim to simplify extended protection for medicinal products through a unitary supplementary protection certificate
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA, Technology and IP Attorneys explore the factors driving rapid growth in India's medical tourism industry as fraudulent healthcare providers attempt to cash in
